Marijuana is gaining momentum as a miracle drug for treating a wide array of diseases, and that's thanks to its chemical compounds like terpenes and cannabinoids that interact with the endocannabinoid system to produce symptom relief. The non-psychoactive component, cannabidiol (CBD), reduces inflammation, alleviates symptoms of epilepsy, reduces psychosis, and relieves pain and discomfort. Pharmaceutical companies and scientists are studying the effects of CBD-based medications on cancer, multiple sclerosis, epilepsy, and more.
The cannabinoid well-known for its psychoactive effects, tetrahydrocannabinol (THC), could be applicable in treatment regimens in oncology and psychiatry. The cannabinoid can suppress vomiting and nausea and stimulate appetite, all of which could be useful in supplementing chemotherapy treatments. THC's effects on memory could also be beneficial for those who suffer from PTSD or anxiety. THC's ability to blunt the impact of emotional trauma allows patients to overcome or manage their emotional pain.
This information has been brought to you by the Medicinal Marijuana Association and approved by our Chief Medical Officer.